Dermalex Psoriasis

Clinical evidence and proven efficacy

The clinical tests were conducted by dermatologists on patients with several Psoriasis symptoms and years of age based on the international objective standard used by dermatologists to assess the effi cacy of a product against Psoriasis, PASI (Psoriasis Area and Severity Index) showing remarkable improvement of the treated Psoriasis symptoms:

  • 80% of patients tested achieved minimum 50% decrease of their Psoriasis symptoms (80% – PASI 50)
  • Almost 50% of patients testes achieved 75% decrease of the symptoms (46,7% – PASI 75)
  • On average, patients had 71% improvement of the symptoms

When asked, the patients tested support and even strengthen the exceptional results of the clinical study:

  • 75% indicated a minimum of 80% improvement of their quality of life
  • 83% indicated a minimum of 70% of symptom disappearance
    • 79% achieved an (almost) disappearance of scaling
    • 60% indicated an itch reduction already after a maximum of 5 days

PASI based clinical efficacy study of Dermalex Psoriasis cream for the treatment of Psoriasis Vulgaris symptoms in a mono application therapy, Józsefváros Health Center, Budapest, Hungary; Open Label Clinical Study into the overall effi cacy of Dermalex Psoriasis Cream, 2008, Dermatology and Psoriasis Clinics Laudau and Kandel, Germany

Improvement thanks to Dermalex Psoriasis